To use all functions of this page, please activate cookies in your browser.
My watch list
my.bionity.com
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
3,434 Current news from the ressort business
rss |
You can refine your search further. Select from the filter options on the left to narrow down your results. |
First generation of real microbiome-based therapeutics
Microbiome therapeutics biotech mbiomics raises EUR 13 million in first closing of Series A round
28-Mar-2023
mbiomics GmbH, a pioneering microbiome biotech company developing the first generation of effective microbiome-based therapeutics announced the first closing of EUR13 million (US$ 15 million) of a series A financing round led by MIG Capital. High-Tech Gründerfonds and Bayern Kapital joined the ...
Evotec receives US$ 6.6 m grant for drug discovery in tuberculosis
24-Mar-2023
Evotec SE announced that the Company has received a US$ 6.6 m grant from The Bill & Melinda Gates Foundation for drug discovery in tuberculosis (“TB”). The grant is the second award from the foundation to Evotec supporting TB drug discovery, and allows the Company to progress a portfolio of TB ...
12 million Euros for a novel gene editing platform
Start-up aims to revolutionize treatment of severe diseases
23-Mar-2023
Seamless Therapeutics, a Dresden based start-up of the Technische Universität Dresden, announced a $12.5 million (€11.8M) seed financing round which will accelerate further development of its designer recombinases, a novel gene editing platform to transform the treatment of severe diseases. ...
New checkpoint antibody against cancer
BioNTech and OncoC4 announce strategic collaboration
22-Mar-2023
BioNTech SE and OncoC4, Inc., a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel biologicals for cancer treatment, announced that they have entered into an exclusive worldwide license and collaboration agreement to develop and commercialize OncoC4’s ...
225 million euros for start-ups of the Max Planck Society
2022 brought record investment sums for research-based start-ups managed by Max Planck Innovation
21-Mar-2023
A successful business year for Max Planck Innovation includes increasing investment sums for the start-ups managed. Especially life sciences start-ups with a high degree of maturity provided a record sum of 225 million euros. Companies in the Max Planck Innovation investment portfolio raised over ...
Successful exit: Miltenyi Biotec acquires biosensor company lino Biotech
21-Mar-2023
lino Biotech, a biosensor company and the world’s only provider of Focal Molography®, announced it has been acquired by Miltenyi Biotec, a global biotech company based in Germany, on February 22, 2023. Since its founding in 2020, lino Biotech has made significant advances in developing new ...
INTEGRA Biosciences acquires start-up Miroculus to accelerate genomics
20-Mar-2023
INTEGRA Biosciences announced that it has acquired Miroculus, a biotechnology specialist focused on developing hands-off automation solutions for next generation sequencing (NGS) protocols. This will allow INTEGRA to expand its product range for library preparation, offering significant time ...
GSG GENII Software Group acquires iVention
17-Mar-2023
GSG GENII Software Group announces that it has completed the acquisition of iVention. iVention provides laboratories in a wide range of industries with its powerful and flexible iVention Lab Execution System (iLES), a software system designed specifically for and around the laboratory process. ...
BluCon Biotech and LG Chem enter into unique investment agreement
BluCon Biotech's technology has the potential to be a disruptive game changer in the world's plastics market
16-Mar-2023
BluCon Biotech, a German biotech company, and LG Chem,a Korean chemical company, have entered into an investment agreement to scale up and commercialize BluCon Biotech’s proprietary technology to supplement LG Chem´s bio-economy portfolio BluCon Biotech’s technology has the potential to be a ...
Massive efforts needed to reduce salt intake and protect lives
15-Mar-2023
A first-of-its-kind World Health Organization (WHO) Global report on sodium intake reduction shows that the world is off-track to achieve its global target of reducing sodium intake by 30% by 2025. Sodium, an essential nutrient, increases the risk of heart disease, stroke and premature death ...
